首页|护理主导的耳穴压豆疗法对乳腺癌化疗所致周围神经病变的疗效观察

护理主导的耳穴压豆疗法对乳腺癌化疗所致周围神经病变的疗效观察

扫码查看
目的 观察护理主导的耳穴压豆疗法在改善紫杉醇类药物化疗乳腺癌患者周围神经病变症状中的效果。方法 将86例患者随机分为研究组和对照组,每组43例。研究组采用传统西医治疗结合耳穴压豆法进行干预,对照组采用传统西医治疗。比较2组患者临床疗效及周围神经病变症状评分。结果 治疗后,2组患者肢体麻木、肢体疼痛、倦怠乏力和腱反射评分均低于治疗前,且研究组患者上述评分低于对照组,差异均有统计学意义(P<0。05)。研究组患者总有效率为88。4%(38/43),高于对照组的74。4%(32/43),差异有统计学意义(P<0。05)。结论 护理主导的耳穴压豆疗法联合甲钴胺可改善接受紫杉醇类药物治疗的乳腺癌患者周围神经毒性症状,具有无创简单、安全灵活、经济实用、依从性好等优势。
Effect of nursing-led auricular acupressure on chemotherapy-induced peripheral neuropathy of patients with breast cancer
Objective To observe the effect of nursing-led auricular acupressure therapy in im-proving the symptoms of peripheral neuropathy in breast cancer patients with chemotherapy of paclita-xel.Methods A total of 86 patients were randomly divided into study group and control group,with 43 cases in each group.The study group was treated with traditional western medicine and auricular acupressure,while the control group was treated with traditional western medicine alone.The clinical efficacy and scores of peripheral neuropathy symptoms were compared between the two groups.Results After treatment,the scores of limb numbness,limb pain,fatigue and tendon reflex in both groups were significantly lower than those before treatment,and the scores of the above symptoms in the study group were significantly lower than those in the control group(P<0.05).The total effective rate of the study group was 88.4%(38/43),which was significantly higher than 74.4%(32/43)in the control group(P<0.05).Conclusion The nursing-led auricular acupressure therapy combined with mecobalamin can improve the symptoms of peripheral neurotoxicity in breast cancer patients trea-ted with paclitaxel,with the advantages of non-invasiveness,simplicity,safety,flexibility,cost-effec-tiveness,and good compliance.

nursingauricular acupressure therapybreast cancerchemotherapyperipheral neuropathypaclitaxel

金慧、史文俊、蒋威华、张英

展开 >

新疆医科大学附属肿瘤医院头颈外科,新疆乌鲁木齐,830011

护理 耳穴压豆疗法 乳腺癌 化疗 周围神经病变 紫杉醇

天山青年人才计划项目

2020Q042

2024

实用临床医药杂志
扬州大学,中国高校科技期刊研究会

实用临床医药杂志

CSTPCD
影响因子:1.543
ISSN:1672-2353
年,卷(期):2024.28(16)
  • 4